Table 3.
Comparison of seroprevalence rates per animal species between seroprevalences recorded in different countries and the results of our study.
| Prevalence from literature | Seroprevalence in our study | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Species /Expected genotype | Method ELISA | Method PCR | ||||||||
| Percent | Positive / Total | Method ELISA Used | Percent (%) | Positive / Total | Ref* | Countries / Year of study | Percent | Positive/Total | IC 95% | |
| Rabbit Gen: 3 | 54.6 | 65/119 | Commercial kit (Wantai) | 6.9 | 8/115 | Geng et al. (2011a) | China (North) / 2010 | 60.0 | 60/100 | [50.4–69.6] |
| 37.3 | 47/126 | Commercial kit (Wantai) | 17.1 | 28/164 | Hammerschmidt et al. (2017) | Germany / 2016 | ||||
| 36.0 | 31/85 | In-house test | 16.0 | 14/85 | Cossaboom et al. (2011) | USA (Virginia) / 2011 | ||||
| 57.0 | 191/335 | Commercial kit (Wantai) | 7.6 | 11/144 | Zhao et al. (2009) | China (North) / 2009 | ||||
| 15.4 | 169/1094 | Commercial kit (Wantai) | 2.0 | 22/1094 | Geng et al. (2011a) | China (North; Northeast; North; South East; South) / 2010 | ||||
| 3.4 | 7/206 | In-house test | 0.0 | 0/206 | Di Bartolo et al. (2016) | Italy / 2015 | ||||
| 72.5 and 62.5 | 58/80 and 50/80 | Commercial kit (Wantai) for human and In-house test for swine sera | 46.1 | 24/52 | Liu et al. (2017) | China (Center) / 2017 | ||||
| Hare | 2.2 | 14/624 | Commercial kit (Axiom corresponding to the assay produced by Wantai,) | 0.0 | 0/624 | Hammerschmidt et al. (2017) | Germany / 2016 | 52.6 | 10/19 | [30.2–75.1] |
| 0.0 | Commercial kit (DIA.PRO) | – | – | Mazzei et al. (2015) | Italy / 2015 | |||||
| Cattle Gen: 4d | 15.0 | 52/346 | Commercial kit (Wantai) | – | – | Geng et al. (2010a) | China (North) / 2010 | 26.4 | 19/72 | [16.2–36.6] |
| 28.2 | 257/912 | Commercial kit (Wantai) | 0.8 | 7/912 | Geng et al. (2010a) | China / 2008 (center, North, South, East and West) | ||||
| 6.0 | 6/100 | Commercial kit (Wantai) | 0.0 | 0/100 | Zhang et al. (2008) | China (East) / 2004-2006 | ||||
| 15.0 | 174/1156 | In-house test | – | – | Dong et al. (2011) | USA (Virginia) / 2011 | ||||
| Sheep Gen: 4d | 100.0 And 77.5% | 58/58 And 45/58 | Genelabs Diagnostics (Commercial kit) and In-house test | 0.0 | 0/58 | Shukla et al. (2007) | India / 2006 | 12.0 | 9/75 | [4.6–19.3] |
| 10.5 | 2/19 | Diagnostic Automation (commercial kit for human) | – | – | Junaid et al. (2014) | Nigeria / 2012 | ||||
| 31.8 | 56/176 | ID-vet (commercial kit) | – | – | Shuaibu et al. (2016) | Nigeria / 2016 | ||||
| 35.2 | 176/500 | Commercial kit (Wantai) | 5.3 | 4/75 | Wu et al. (2015) | China (West) / 2014 | ||||
| Goat Gen: 3c | 100.0 | 86/86 | Genelabs Diagnostics (Commercial kit) and In-house test | 0.0 | 0/86 | Shukla et al. (2007) | India / 2006 | 28.4 | 23/81 | [18.6–38.2] |
| 10.4 | 73/700 | Commercial kit (Wantai) | 1.6 | 11/700 | Geng et al., (2010)a | China (center, North, South, East and West) / 2008 | ||||
| 37.2 | 16/43 | Diagnostic Automation (commercial kit for human | – | – | Junaid et al. (2014) | Nigeria / 2012 | ||||
| 16.0 | 13/80 | In-house test | 0.0 | 0/80 | Sanford et al. (2013) | USA (Virginia) / 2002 | ||||
| 24.0 | 12/50 | Commercial kit (Wantai) | 0.0 | 0/50 | Zhang et al. (2008) | China (East) / 2004-2006 | ||||
| 0.0 | 0/5 | In-house test | – | – | Vitral et al. (2005) | Brasil / 2005 | ||||
Note: * references.